Cervical Cancer

How self-collection* and extended genotyping may help improve screening rates and support risk stratification

Offering HPV self-collection kits during routine GP appointments boosts screening rates among overdue women, helping prevent cervical cancer

ADLM 2025 studies highlight promising options for cervical and endometrial cancer testing

At the ADLM 2025, Roche highlights advances in diagnostics, including digital health solutions, mass spectrometry, and expanded access to testing across care settings

Screening is usually discontinued for women 65+ if their previous smear tests were normal despite rising global incidence of cervical cancer in this age group

Study of nearly 2,500 women in Texas found self-collection tests were effective at increasing cervical cancer screening participation in underserved US population

Screening successes, emerging technologies, precision treatments, and other steps forward from the AACR Cancer Progress Report 2024

First genome-wide association study finds variants linked to susceptibility of cervical cancer-causing virus

The survey findings reveal that women with metabolic syndrome have a 65 percent higher heart disease risk

Do you know which test is more accurate? Survey highlights need for better education around cervical cancer screening tests